simplify.education

computational biology and simulation · BEGINNER LESSON

In silico

In silico means using a computer-based simulation or other computational model to study a system, instead of testing only in a physical experiment. In the sources here, it is used for simulated clinical care pathways, disease models, and virtual trials that help evaluate ideas before real-world use.

What it is

In silico work uses a computer program to represent part of the real world, such as a clinical care pathway, a disease process, or a trial design. The sources define in silico evaluation as using simulated clinical care pathways and workflows with a computer program to evaluate a clinical decision support system (CDSS), and also describe in silico approaches as models, machine learning, simulations, and digital twins that support disease research and virtual trials. A CDSS is a clinical decision support system, meaning software that helps health professionals make decisions. [0,1]

[1] In Silico Evaluation of Algorithm-Based Clinical Decision ... [2] Advancing the frontier of rare disease modeling: a critical appraisal of in silico technologies - PubMed

What is measured or assessed

The goal is usually to estimate what would happen under different choices before a real implementation or experiment. In the sources, this includes patient outcomes, workflow effects, cost-effectiveness, diagnosis and disease characterisation, drug discovery, non-clinical development, and clinical trial design. So the thing being assessed is not a physical sample itself, but predicted effects produced by the model. [0,1]

[1] In Silico Evaluation of Algorithm-Based Clinical Decision ... [2] Advancing the frontier of rare disease modeling: a critical appraisal of in silico technologies - PubMed

How it works

The computer model is built to mimic important parts of the target system. For care pathways, the model must handle changing conditions over time, random variation, provider and patient preferences, and resource limits. For rare disease research, models may combine genomic data, structural modelling, and machine learning to deal with scarce and fragmented data. A digital twin is a computer representation of a real system used for comparison or simulation. [0,1]

[1] In Silico Evaluation of Algorithm-Based Clinical Decision ... [2] Advancing the frontier of rare disease modeling: a critical appraisal of in silico technologies - PubMed

Why it is useful

These methods can be useful when real-world testing is slow, expensive, hard to scale, or impractical. The sources say they can provide broader assessment before implementation, help when patient data are scarce, and support questions that range from diagnosis to drug discovery and clinical trial planning. [0,1]

[1] In Silico Evaluation of Algorithm-Based Clinical Decision ... [2] Advancing the frontier of rare disease modeling: a critical appraisal of in silico technologies - PubMed

Limitations

The sources also stress important limits. Models may need large, well-annotated datasets, but rare disease data are often incomplete, fragmented, or non-standardised. Validation can be weak because standard testing protocols are lacking, and reproducibility can suffer when assumptions, code, or versioning are poorly documented. For machine learning models, performance may not match expert judgment, and some methods can overfit when data are limited. [1]

[2] Advancing the frontier of rare disease modeling: a critical appraisal of in silico technologies - PubMed

SEE THE IDEA

How an in silico study works

Question -> model built from data -> simulation run -> predicted outcomes compared before real-world use

An in silico study uses a computer representation of a system to estimate outcomes before or alongside real testing.

TRY IT YOURSELF

Test your understanding

Choose an answer, then check the explanation.

0 of 3 questions answered
01 Which choice best describes in silico evaluation in the sources?
02 A team is studying a rare disease and combines genomic data, structural modelling, and machine learning because patient samples are scarce. What is this an example of?
03 Which limitation is most clearly supported by the sources?

PUT IT TOGETHER

Match each concept to its meaning

Drag a label onto its description, or select a label and then select a description. This also works with a keyboard.

Sources and further reading

This general lesson was generated from public source material. It explains a concept; it does not interpret a private paper or provide medical advice.

  1. In Silico Evaluation of Algorithm-Based Clinical Decision ...
  2. Advancing the frontier of rare disease modeling: a critical appraisal of in silico technologies - PubMed
  3. Advancing the frontier of rare disease modeling: a critical appraisal of in silico technologies
Apply this to a paper →